DoctorBase releases Panda 6 – the first HIPAA-Omnibus compliant private social platform for doctor-patient communications exceeding meaningful use by 7.5%.
DoctorBase.com, a leading mHealth-as-a-Service platform for medical practices, today announced the release of its cloud-based, mobile medical software, Panda 6. The product integrates with 14 legacy patient portals with extensive enhancements to its HIPAA-compliant secure mobile messaging platform that achieved 12.5% patient usage in extensive beta trials.
90% of patients are open to using mobile health apps and 62% of doctors report using iPads and tablets. Panda 6 is built on a mobile friendly architecture that works on any Android or iOS device. The platform is now pushing nearly 7,000 messages between patients and doctors per day.
The platform is also designed to help struggling physicians meet the 5% patient usage requirements for Meaningful Use Stage 2 that requires physicians to make a patient portal available to patients to access, print, share or download their records. Initially, the rules required 10% of their patients use the technology, but the final rules were reduced to 5% after physicians including the American Medical Association (AMA) expressed their struggles surrounding forcing patients to engage with providers.
For larger IPAs and ACOs, Panda 6 patient portal integrations provide a Mobile Wrapper that can help turn struggling patient usage statistics around without costly forklift upgrades. According to data recently released by the American Academy of Physicians, 20% of practices that attested to Stage 2 in 2011 failed to do so in 2012.
“It scares me when large medical organizations suddenly release their own desktop-only messaging platforms. Three years of data and user feedback went into Panda, and leveraging mobile devices is the only way to move past 5%,” said DoctorBase Chief Executive Officer John Sung Kim.
Latest posts by Fred Pennic (see all)
- 3 Big Predictions for the Global Healthcare Market in 2014 - December 9, 2013
- 7 Security Trends Healthcare Organizations Will Confront in 2014 - December 6, 2013
- NYC Starts $100M Biotech Fund To Invest in Life Sciences Companies - December 4, 2013